Ozempic Cost Without Insurance: 2026 Prices and Cheaper Routes

The cash price is the last resort, not the first. Four routes can cost you far less, and which one fits depends on your insurance.

Novo Nordisk’s Patient Assistance Program “provides medicine at no cost to those who qualify,” with no registration charge or monthly fee. For 2026, you must be a U.S. citizen or legal resident, have Medicare or no insurance, meet the household income limit, and not be enrolled in or qualify for Medicaid, the Medicare Low-Income Subsidy, or VA benefits. If you’re uninsured, you’ll need a copy of your state Medicaid denial letter.

Ozempic injection (0.5 mg, 1 mg and 2 mg) is on the program’s product list for uninsured patients only. Wegovy isn’t on the list. Apply online through NovoCare or call Novo Nordisk at 1-866-310-7549, and don’t pay a third party to apply for you.

From July 1, 2026 through December 31, 2027, Medicare’s GLP-1 Bridge covers Wegovy (injection or tablet), Foundayo, and the Zepbound KwikPen for people with Part D coverage who qualify, at a $50 monthly copay. Eligibility runs on BMI plus certain conditions: for example, a BMI of 35 or higher, or a BMI of 27 or higher with prediabetes or a previous heart attack or stroke. The $50 doesn’t count toward your Part D out-of-pocket costs, and the Low-Income Subsidy doesn’t apply to it.

Ozempic itself isn’t on the Bridge list. If you have type 2 diabetes, you aren’t eligible for the Bridge, but Medicare says your Part D plan might cover your GLP-1. Our guide to who qualifies for the Medicare GLP-1 Bridge walks through every criterion.

Federal law lets state Medicaid programs exclude drugs “when used for anorexia, weight loss, or weight gain,” so whether Medicaid pays for a GLP-1 for weight loss depends on your state. Our guide on how to get a GLP-1 covered in 2026 maps the Medicaid, Medicare, and job-based routes from the primary sources.

If your private insurance covers Ozempic, Novo Nordisk’s savings offer can bring your cost down to as little as $25 a month, with a maximum savings of $100 a month, for up to 48 months. Wegovy has the same $25 offer. People with government coverage, such as Medicare or Medicaid, can’t use it.

If none of those fit, Novo Nordisk sells both drugs for cash through NovoCare Pharmacy, with free home delivery or pickup at a local pharmacy. These are the company’s own self-pay prices from its price guides. A month means one Ozempic pen, one box of four Wegovy pens, or a bottle of 30 tablets.

Two details matter. The $199 starter price is for patients new to the savings offer or NovoCare Pharmacy, for two monthly fills through December 31, 2026. And Ozempic is approved to improve blood sugar in adults with type 2 diabetes, while Wegovy is approved to help with weight loss and to lower heart risk in some adults, so the name on your prescription decides which price and which coverage rules apply to you.

For the clinical evidence behind semaglutide, see our review of Ozempic and Wegovy in Black patients and our plain-language semaglutide overview.

Licensed telehealth services can evaluate you and write a prescription. Ask any service two things before you pay: does it prescribe the FDA-approved brand, and does it send that prescription to a state-licensed pharmacy such as NovoCare? If the answer is a compounded version, that’s a different product (see the warning below). Our online GLP-1 guide by state covers the options where you live.

If you have an FSA or HSA, ask the plan administrator whether your prescription qualifies and whether it needs a letter of medical necessity. Pre-tax dollars stack on top of the self-pay price.

A denial letter is the beginning of a process, not a closed door. Make these three moves:

1. Ask for the coverage criteria in writing. Have your prescriber’s office request the plan’s specific requirements for semaglutide. Sometimes the issue is a missing prior authorization or an unmet step, not a true no.
2. Get the prescriber to submit a prior authorization documenting your diagnosis, prior treatments, and medical necessity.
3. File a formal appeal. You have the right to an internal appeal, and after that to an external review by an independent third party. A letter of medical necessity from your clinician, citing your diagnosis and history, is the core of a strong appeal.

To find a clinician who can prescribe and help with coverage, use our provider directory.

The cheapest listings online are cheap for a reason, and the FDA has been blunt about the danger.

The safe rule is simple: get a prescription from a licensed clinician and fill it at a state-licensed pharmacy. The FDA’s BeSafeRx resources help you check whether an online pharmacy is legitimate, and our explainer on the FDA’s compounded GLP-1 crackdown covers what changed. A drug that costs less but contains the wrong dose isn’t a bargain.